{"id":3590,"date":"2025-09-16T13:39:57","date_gmt":"2025-09-16T13:39:57","guid":{"rendered":"https:\/\/thetradingdictionary.com\/index.php\/2025\/09\/16\/lobe-sciences-ltd-to-attend-the-arcstone-kingswood-growth-summit-2025-in-toronto\/"},"modified":"2025-09-16T13:39:57","modified_gmt":"2025-09-16T13:39:57","slug":"lobe-sciences-ltd-to-attend-the-arcstone-kingswood-growth-summit-2025-in-toronto","status":"publish","type":"post","link":"https:\/\/thetradingdictionary.com\/index.php\/2025\/09\/16\/lobe-sciences-ltd-to-attend-the-arcstone-kingswood-growth-summit-2025-in-toronto\/","title":{"rendered":"Lobe Sciences Ltd. to Attend the ArcStone-Kingswood Growth Summit 2025 in Toronto"},"content":{"rendered":"<\/p>\n<div>\n<p>lobe sciences ltd.\u00a0(CSE: LOBE,OTC:LOBEF) (OTCQB: LOBEF) (FSE: LOBE.F)\u00a0(&#8216;Lobe Sciences&#8217; or the &#8216;Company&#8217;) a clinical stage biopharmaceutical company focused on developing products to treat diseases with significant unmet medical needs is pleased to announce its participation in the upcoming ArcStone-Kingswood Growth Summit in Toronto, taking place at the St. Regis Toronto on September 18, 2025. Dr. Frederick D Sancilio, CEO of lobe sciences ltd. will be presenting the company&#8217;s recent milestones and future growth strategy.<\/p>\n<p>The ArcStone-Kingswood Growth Summit will be hosting over 20 companies and a curated group of investors for a full day of pre-arranged, targeted 1-on-1 meetings, panel discussions and networking opportunities. <\/p>\n<\/p>\n<p>Alongside the schedule of pre-booked meetings matching investors with appropriate projects, the conference program will provide amble opportunities to mix and mingle with the industry professionals and catch up on key industry developments. <\/p>\n<p>Interested investors who would like to attend the ArcStone-Kingswood Growth Summit can register to request for a free invitation here.<\/p>\n<p><b>About ArcStone Securities and Investments Corp.<\/b><\/p>\n<p>ArcStone Securities and Investments Corp. is a diversified financial services firm with offices in Toronto and New York. Our firm specializes in providing bespoke solutions to mid-market companies worldwide, with a particular focus on cross-border transactions between Canada and the United States. Our partnership with Kingswood US enhances our ability to offer a full spectrum of financial services to our clients.<\/p>\n<p><b>About Kingswood US<\/b><\/p>\n<p>Kingswood US is a mid-market investment bank with a strong retail equity capital markets franchise and deep-rooted investment bank. The firm is dedicated to providing comprehensive financial services, including investment banking, wealth management, and capital raising, to clients across the United States.<\/p>\n<p><b>About lobe sciences ltd. <\/b><\/p>\n<p><b>Lobe Sciences Ltd<\/b>. is a clinical stage biopharmaceutical company focused on developing novel therapies for rare neurological and hematological conditions. The company operates through two subsidiaries:<\/p>\n<ul class=\"ee-ul\">\n<li>\n<p><b>Altemia, Inc.<\/b> is addressing sickle cell disease with two complementary assets: a medical food currently in early-stage distribution, and S-100, a patent-pending therapeutic candidate designed to treat the underlying pathology of the disease.<\/p>\n<\/li>\n<\/ul>\n<p>Lobe&#8217;s pipeline is differentiated by intellectual property, clinical momentum, and a strategic focus on high-value, underserved markets.<\/p>\n<div>\n<p>For additional Information, please contact:<\/p>\n<p>lobe sciences ltd. <br \/>info@lobesciences.com <br \/>www.lobesciences.com <\/p>\n<\/div>\n<p>To view the source version of this press release, please visit https:\/\/www.newsfilecorp.com\/release\/265683<\/p>\n<\/p>\n<\/div>\n<p>News Provided by Newsfile via QuoteMedia<\/p>\n<\/p>\n<div>This post appeared first on investingnews.com<\/div>\n<p><\/p>\n","protected":false},"excerpt":{"rendered":"<p>lobe sciences ltd.\u00a0(CSE: LOBE,OTC:LOBEF) (OTCQB: LOBEF) (FSE: LOBE.F)\u00a0(&#8216;Lobe Sciences&#8217; or the &#8216;Company&#8217;) a clinical stage biopharmaceutical company focused on developing products to treat diseases with significant unmet medical needs is pleased to announce its participation in the upcoming ArcStone-Kingswood Growth Summit in Toronto, taking place at the St. Regis Toronto on September 18, 2025. Dr.&hellip;<\/p>\n","protected":false},"author":1,"featured_media":3591,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[3],"tags":[],"class_list":["post-3590","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-investing"],"_links":{"self":[{"href":"https:\/\/thetradingdictionary.com\/index.php\/wp-json\/wp\/v2\/posts\/3590","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/thetradingdictionary.com\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/thetradingdictionary.com\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/thetradingdictionary.com\/index.php\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/thetradingdictionary.com\/index.php\/wp-json\/wp\/v2\/comments?post=3590"}],"version-history":[{"count":0,"href":"https:\/\/thetradingdictionary.com\/index.php\/wp-json\/wp\/v2\/posts\/3590\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/thetradingdictionary.com\/index.php\/wp-json\/wp\/v2\/media\/3591"}],"wp:attachment":[{"href":"https:\/\/thetradingdictionary.com\/index.php\/wp-json\/wp\/v2\/media?parent=3590"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/thetradingdictionary.com\/index.php\/wp-json\/wp\/v2\/categories?post=3590"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/thetradingdictionary.com\/index.php\/wp-json\/wp\/v2\/tags?post=3590"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}